Table 1.
Baseline Clinical Characteristics of All First-Episode Schizophrenia Patients
| Whole Sample (n=569) |
Male (n=283) |
Female (n=286) |
p value | Effect Size | |
|---|---|---|---|---|---|
| Age at study entry (95% CI) | 25.0(24.4, 25.6) | 24.18(23.44,24.92) | 25.84(24.91,26.76) | <0.01 | 0.83 |
| Patients disposition | |||||
| Risperidone | 190(33.4) | 100(34.6) | 90(31.1) | 0.66 | 0.38 |
| Olanzapine | 185(32.5) | 89(30.8) | 96(34.3) | ||
| Aripiprazole | 194(34.1) | 94(33.5) | 100(34.6) | ||
| Psychopathology (95% CI) | |||||
| PPANSS | 23.41(22.96–23.85) | 23.74(23.08–24.41) | 23.08(22.49–23.67) | 0.14 | 0.63 |
| NPANSS | 21.09(20.48–21.71) | 22.07(21.23–22.90) | 20.13(19.24–21.02) | <0.01 | 0.36 |
| GPANSS | 41.79(41.14–42.45) | 42.46(41.51–43.42) | 41.13(40.23–42.03) | 0.04 | 0.57 |
| PANSS Total | 86.30(85.1–87.5) | 88.27(86.53–90.01) | 84.34(82.63–86.05) | <0.01 | 0.56 |
| PSP scores | 41.58(40.50–42.67) | 40.70(39.14–42.26) | 42.45(40.95–43.96) | 0.11 | 0.65 |
Note: Significant results are shown in bold.
Abbreviations: PPANSS, positive PANSS subscale score; NPANSS, negative PANSS subscale score; GPANSS, general PANSS, subscale score; PSP, Personal and Social Performance Scale; CI, confidence interval.